A novel method detecting the key clinic factors of portal vein system thrombosis of splenectomy & cardia devascularization patients for cirrhosis & portal hypertension

Table 2 Performance of PVST predictive models on different sets of risk indicators of 5-fold cross validation experiments

Fold (C, γ)	Acc	AUC	Sensitivity	Specificity	Precision	F-measure	FNR	FPR	FDR	MCC	# selected features
1 (2,0.0625)	0.68	0.91	0.64	0.75	0.78	0.70	0.36	0.25	0.22	0.38	1
1 (2,0.0625)	0.74	0.89	0.91	0.50	0.71	0.80	0.09	0.50	0.29	0.46	2
2 (0.25,0.25)	0.74	0.84	1	0.38	0.69	0.81	0	0.62	0.31	0.51	2
2 (0.25,0.25)	0.89	0.84	1	0.75	0.85	0.92	0	0.25	0.15	0.80	8
3 (0.125,16)	0.61	0.85	0.70	0.50	0.64	0.67	0.30	0.50	0.36	0.20	2
	0.72	0.59	0.90	0.50	0.69	0.78	0.10	0.50	0.31	0.44	4
	0.61	0.76	0.80	0.38	0.62	0.70	0.20	0.62	0.38	0.19	6
4 (0.25,0.0625)	0.33	0.55	0.40	0.25	0.40	0.40	0.60	0.75	0.60	−0.35	1
	0.33	0.44	0.40	0.25	0.40	0.40	0.60	0.75	0.60	−0.35	2
	0.33	0.23	0.50	0.13	0.42	0.45	0.50	0.87	0.58	− 0.40	4
5 (0.5,0.125)	0.56	0.80	0.60	0.50	0.60	0.60	0.40	0.50	0.40	0.10	1
	0.56	0.70	0.50	0.63	0.63	0.56	0.50	0.37	0.37	0.13	3
	0.61	0.65	0.80	0.38	0.62	0.70	0.20	0.62	0.38	0.19	5
Average	0.59	0.70	0.70	0.45	0.62	0.65	0.30	0.55	0.38	0.18	–